Science and Technology Minister Dr Jitendra Singh has said that large-scale genome sequencing initiatives supported by the Department of Biotechnology (DBT) are already AI-enabled. Dr Singh said this in the backdrop of the ongoing India AI Impact Summit 2026. The Minister noted that AI-driven gene sequencing promises to power India’s transition towards personalised medical prescriptions and predictive medicine.

He further underlined that DBT’s genomics ecosystem is positioning the country towards precision healthcare driven by data and computational biology. Reinforcing this shift, Dr Singh announced that DBT, along with the Biotechnology Industry Research Assistance Council, will establish Bio-AI Mulankur hubs this year to create integrated, closed-loop research platforms where AI-based predictions and laboratory validation operate in a unified framework. He added that embedding AI across DBT’s genomics platforms will strengthen predictive healthcare, disease surveillance and advanced bio-manufacturing capabilities.